|
Sunday, May 02, 2010
1:00 PM - 3:00 PM |
| Session Number: 2612 |
| Diabetes: Beyond Type 1 |
| PAS Topic Symposium |
| Vancouver Convention Centre ~ 301-305 |
| |
| Target Audience: Endocrinologists, geneticists, general pediatricians. |
| |
| Objectives:
- Understand which individuals should be screened for genetic forms of DM[br]- Improve their ability to diagnose and manage monogenic causes of DM[br]- Understand the mechanisms underlying these conditions |
| |
| Chairs: Joseph I. Wolfsdorf, Children[apos]s Hospital Boston, Boston, MA and Cem Demerci, Connecticut Children[apos]s Medical Center, Hartford, CT |
| |
| Monogenic forms of diabetes yield critical insights into the mechanisms of glucose control. Identification of individuals with non-type 1/non-type 2 DM may have implications for specific targeted therapeutic approaches and long-term prognosis. This session will provide new insights on genetic defects along the pathway of insulin action and signaling that can lead to disruption of glucose control. |
| |
| - |
Joseph I. Wolfsdorf
Children[apos]s Hospital Boston, Boston, MA |
| - |
Cem Demirci
Connecticut Children's Medical Center, Hartford, CT |
| 1:00 PM - |
Monogenic Diabetes: When To Screen and How To Treat
Diva D. De León Crutchlow
The Children[apos]s Hospital of Philadelphia, Philadelphia, PA |
| 1:30 PM - |
Neonatal Diabetes: Channelopathies and Beyond
Siri Atma W. Greeley
University of Chicago Comer Children[apos]s Hospital, Chicago, IL |
| 2:00 PM - |
Mitochondrial Diabetes
Douglas Wallace
Center for Molecular and Mitochondrial Medicine and Genetics (MAMMAG), University of California, Irvine, CA |
| 2:30 PM - |
Lipodystrophies
Abhimanyu Garg
University of Texas Southwestern Medical Center, Dallas, TX |
|
| |
| Program developed by the Lawson Wilkins Pediatric Endocrine Society and the Pediatric Academic Societies |
| |
|
